Bioleaders Corporation (142760) — Cash Flow Reinvestment Rate
Bioleaders Corporation (142760) has a Cash Flow Reinvestment Rate of 76.60x as of September 2024, reinvesting ₩3.80 Billion (capex ₩1.04 Billion plus investments ₩2.75 Billion) from operating cash flow of ₩49.56 Million. Explore Bioleaders Corporation capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Bioleaders Corporation Cash Flow Reinvestment Rate (2023–2023)
Historical reinvestment intensity for Bioleaders Corporation across 1 annual periods. Also explore 142760 total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Bioleaders Corporation (2023–2023)
Year-by-year capital reinvestment analysis for Bioleaders Corporation. For live market cap and broader valuation context, see 142760 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 5.01x | ₩30.93 Billion | ₩6.18 Billion | ₩378.81 Million | — |